Axalta Coating Systems Ltd

1. 1

   The Bye‑Laws Proposal

   ManagementBoard: FOR

   Approve and adopt an amendment and restatement of Axalta’s bye‑laws to add a new bye‑law requiring that any shareholder resolution to approve a merger or amalgamation be approved by a majority of votes cast by shareholders present (in person or by proxy) and voting, with the quorum set as in bye‑law 26.

   More detail

   This proposal seeks shareholder approval to amend Axalta’s bye‑laws to specify that any resolution to approve a merger or amalgamation will require the affirmative vote of a majority of votes cast by shareholders present and voting, and to set the quorum consistent with bye‑law 26. Management is pursuing this change to replace the default Bermuda Companies Act three‑quarters threshold with a majority‑vote standard that aligns merger approvals with other corporate matters under Axalta’s existing governance framework. The board argues the change provides consistency, reduces uncertainty under Bermuda law, and facilitates the governance mechanics needed for the pending merger transaction. The proposal is presented as a precondition that, if adopted, will lower the shareholder vote threshold required to approve the merger proposal (Proposal 2), potentially making completion simpler if approved. The Axalta Board unanimously recommends a vote FOR, indicating its view that the amendment is in shareholders’ interest and supports the transaction timetable. Opponents might argue that lowering the statutory threshold diminishes protections for minority shareholders by making it easier to approve transformational transactions; the filing notes the change is intended to align thresholds rather than to entrench management. From a governance and takeover‑defense perspective, the change is material because it alters the supermajority requirement that would otherwise apply under Bermuda law and thus affects the bargaining leverage of both shareholders and potential bidders. The board’s recommendation is supported by its assessment of the transaction and by independent fairness analyses described elsewhere in the proxy materials. Given the procedural effect on the subsequent merger vote threshold and the board’s fiduciary framing, the proposal is primarily transactional and governance‑oriented rather than an operational business decision.

2. 2

   The Merger Proposal

   ManagementBoard: FOR

   Approve and adopt the Merger Agreement (dated November 18, 2025, as amended) and the related Bermuda statutory merger agreements and consummate the transactions contemplated by the Merger Agreement, including the combination of Axalta and AkzoNobel.

   More detail

   The Merger Proposal requests shareholder approval to adopt a comprehensive Merger Agreement that would effect a two‑step statutory merger structure (Merger Sub into Axalta, then Axalta into Merger Sub 2) to combine Axalta with AkzoNobel, resulting in MergeCo and an exchange ratio that determines consideration. Management frames the transaction as an all‑stock merger of equals designed to create a global coatings leader with complementary portfolios, scale benefits, procurement and manufacturing synergies, and combined R&D capabilities. The board’s recommendation is supported by due diligence, fairness opinions from Evercore and J.P. Morgan, projected synergies and an analysis that the deal represents the best available option compared with remaining independent or pursuing alternatives. The proxy highlights that the Merger Agreement contains customary representations, covenants, regulatory conditions, and termination/fee provisions (including a €150 million termination payment in certain circumstances). Approval thresholds depend on whether the bye‑laws amendment is adopted; if the bye‑laws amendment passes, a simple majority of votes cast is required for the merger, otherwise a three‑quarters majority under Bermuda law is required. The filing discloses potential conflicts of interest for certain directors and officers (e.g., acceleration of equity awards, retention bonuses, indemnification), which the board considered in its recommendation. The merger is conditioned on a range of regulatory approvals and completion of filings (Form F‑4/Proxy Statement/Prospectus), and the proxy emphasizes risks including integration execution, regulatory divestitures, and potential litigation (e.g., Ichthys litigation). For sophisticated evaluators, the critical issues are transaction certainty, the valuation/exchange ratio fairness analyses, potential dilution and governance arrangements at MergeCo, the enforceability and scope of deal protections, and the sufficiency and realism of the synergy and financial projections underpinning the fairness opinions.

3. 3

   The Advisory Compensation Proposal

   ManagementBoard: FOR

   Nonbinding, advisory vote to approve certain compensation that may be paid or become payable to Axalta’s named executive officers in connection with the merger (as disclosed pursuant to Item 402(t) of Regulation S‑K and described in the proxy), including agreements and plans such as severance and retention arrangements, equity awards, and bonuses.

   More detail

   This nonbinding advisory proposal asks shareholders to approve disclosed merger‑related payments and benefits that may be paid to Axalta’s named executive officers under existing contractual arrangements and plan provisions. The SEC requires an advisory vote for compensation that is transaction‑related; management emphasizes the advisory nature and clarifies that such compensation remains payable under contractual terms regardless of the advisory vote. Management argues shareholder approval is appropriate because these arrangements align executives’ incentives with successful execution of the transaction and long‑term value creation, and seeks a signal of shareholder support for its compensation practices. The proxy directs shareholders to quantified tables and narrative disclosure (Item 402(t) style) and lists specific instruments and plans (severance agreements, retention bonuses, equity vehicles, annual bonuses) that could result in payments. The board recommends FOR the proposal; however, because it is nonbinding, a negative vote would not prevent payments contemplated under the Merger Agreement and existing contracts but could influence future governance and compensation decisions. Governance‑minded investors will weigh the disclosed magnitudes, whether payments are commensurate with market practice, the degree to which they were pre‑negotiated or contingent, and any overlap with protections for directors/officers that could favor insider interests. For evaluation, the key considerations are the transparency and granularity of the Item 402(t) disclosures, the size and structure of potential payments relative to realized deal value, and whether the advisory outcome would prompt remediation or policy changes by the board or compensation committee.

4. 4

   The Adjournment Proposal

   ManagementBoard: FOR

   Authorize the Axalta Board to adjourn the special meeting, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the meeting to approve the merger proposal, subject to limitations in the Merger Agreement (e.g., cannot adjourn beyond 45 days without AkzoNobel consent).

   More detail

   The adjournment proposal asks shareholders to grant the Axalta Board authority to adjourn the special meeting to a later date to continue soliciting proxies if there are insufficient votes to approve the merger at the originally scheduled meeting. Management frames this as a procedural and facilitative measure to allow additional outreach to shareholders, including solicitation of votes from holders who may revoke or change previously submitted proxies. The Merger Agreement constrains adjournment timing—any adjournment cannot extend more than 45 days beyond the original meeting date or be less than five business days prior to the long stop date without AkzoNobel’s consent—so the board’s power is time‑limited. If approved, the board may use the adjournment to attempt to achieve the necessary approval thresholds (which depend on whether the bye‑laws amendment passes). Opponents could view adjournment authority as a mechanism to continue pressure‑solicitation, but it is customary in contested or large‑vote transactions to ensure shareholder voices are solicited. The board’s unanimous FOR recommendation emphasizes its desire to ensure adequate time to solicit proxies and complete the transaction if it believes doing so is in shareholders’ interests. For analysis, reviewers should consider how adjournment authority interacts with solicitation practices, potential dilution or proxy revocations, and whether the company has realistic outreach plans that justify additional solicitation time.

Upcoming shareholder meetings at Axalta Coating Systems Ltd’s closest sector peers — compare boards, ballots, and ownership across the cohort.

When is the Axalta Coating Systems Ltd 2026 special meeting?

Axalta Coating Systems Ltd (AXTA) holds its 2026 special shareholder meeting on Wednesday, August 5, 2026.

What is the record date for the Axalta Coating Systems Ltd 2026 meeting?

The record date for the Axalta Coating Systems Ltd 2026 meeting is Thursday, June 11, 2026. Shareholders of record on or before that date are eligible to vote.

Who are the director nominees for Axalta Coating Systems Ltd's 2026 meeting?

The board is presenting 9 director nominees at the Axalta Coating Systems Ltd 2026 meeting, listed with their independence status and background.

What proposals will shareholders vote on at the Axalta Coating Systems Ltd 2026 meeting?

Shareholders will vote on 4 proposals at the Axalta Coating Systems Ltd 2026 meeting, each tagged with who proposed it and the board's recommendation.